In validation set from GSE36376, downregulation of CYP2A6 and CYP2C8 was also related to poorer RFS in HCC patients (log ranks P = 0.008 and P < 0.001, respectively, Figure 6). This evidence concerns the gene CYP2C8 and hepatocellular carcinoma.